sk&f 86002 has been researched along with Angiogenesis, Pathologic in 2 studies
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sodhi, A | 1 |
| Montaner, S | 1 |
| Patel, V | 1 |
| Zohar, M | 1 |
| Bais, C | 1 |
| Mesri, EA | 1 |
| Gutkind, JS | 1 |
| Haynes, WL | 1 |
| Hirakata, A | 1 |
| Proia, AD | 1 |
2 other studies available for sk&f 86002 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
Topics: 3T3 Cells; Animals; Calcium-Calmodulin-Dependent Protein Kinases; COS Cells; DNA-Binding Proteins; E | 2000 |
Inhibition of corneal neovascularization in the rat by SK&F 86002, a dual inhibitor of arachidonic acid metabolism.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Dose-Response Relationship, Drug; Imidazol | 1992 |